Table 1. Patients’ characteristics.
| Characteristics | Numbers (%) |
|---|---|
| Gender, male:female | 102:37 |
| Subjects performed gene test, n (%) | 58 (41.7) |
| Epilepsy etiology, n (%) | |
| Genetic | 40 (28.8) |
| Structural/metabolic | 42 (30.2) |
| Unknown | 57 (41.07) |
| Classification of epilepsy: syndrome and non-syndrome, n (%) | |
| Syndromes | 25 (18.0) |
| Non-syndrome | 114 (82.0) |
| Classification of epilepsy: infantile spastic and non-infantile spastic, n (%) | |
| infantile spastic | 39 (28.2) |
| non-infantile spastic | 100 (71.9) |
| Seizure type, n (%) | |
| Myoclonic | 9 (6.5) |
| Tonic-clonic | 16 (11.5) |
| Spasm | 47 (33.8) |
| Tonic | 52 (37.4) |
| Absence | 5 (3.6) |
| Others | 10 (7.2) |
| At the beginning of the KD | |
| Age, medium (range, yr) | 5 (4/12–22) |
| Weight, medium (range, Kg) | 12.5 (5–65) |
| Duration of epilepsy, medium (range, mo) | 17 (1–145) |
| Duration of KD, medium (range, mo) | 9 (1–55) |
| Number AEDs, medium (range) | 3 (0–5) |
KD, ketogenic diet; yr, year.